Characterization of killer immunoglobulin-like receptor genetics and comprehensive genotyping by pyrosequencing in rhesus macaques
© Moreland et al; licensee BioMed Central Ltd. 2011
Received: 4 April 2011
Accepted: 7 June 2011
Published: 7 June 2011
Human killer immunoglobulin-like receptors (KIRs) play a critical role in governing the immune response to neoplastic and infectious disease. Rhesus macaques serve as important animal models for many human diseases in which KIRs are implicated; however, the study of KIR activity in this model is hindered by incomplete characterization of KIR genetics.
Here we present a characterization of KIR genetics in rhesus macaques (Macaca mulatta). We conducted a survey of KIRs in this species, identifying 47 novel full-length KIR sequences. Using this expanded sequence library to build upon previous work, we present evidence supporting the existence of 22 Mamu-KIR genes, providing a framework within which to describe macaque KIRs. We also developed a novel pyrosequencing-based technique for KIR genotyping. This method provides both comprehensive KIR genotype and frequency estimates of transcript level, with implications for the study of KIRs in all species.
The results of this study significantly improve our understanding of macaque KIR genetic organization and diversity, with implications for the study of many human diseases that use macaques as a model. The ability to obtain comprehensive KIR genotypes is of basic importance for the study of KIRs, and can easily be adapted to other species. Together these findings both advance the field of macaque KIRs and facilitate future research into the role of KIRs in human disease.
Killer immunoglobulin-like receptors (KIRs) are a highly polymorphic family of cell surface receptors expressed on natural killer (NK) cells and a subset of T-lymphocytes [1–3]. KIR mediated signaling plays a key role in the identification of foreign cells and the antiviral response [4–9]. The best characterized KIR ligands are major histocompatibility complex class I (MHC-I) molecules, although ligands have not been identified for all KIRs [10, 11]. Because both KIRs and MHC-I are highly polymorphic, host genotype plays an important role in KIR function.
KIR genetic diversity can be described in terms of polymorphism and polygenicity. To date, there are 15 KIR genes described in humans . The number of KIR genes varies between individuals, with 7-12 genes per haplotype [13, 14]. Because the protein product of each KIR gene generally binds a unique set of ligands, the subset of KIRs encoded by an individual dictates the potential KIR interactions that can occur. In addition to variation in gene content between haplotypes, there is allelic polymorphism within each KIR gene . Broadly speaking, the allotypic variants encoded by a KIR gene bind the same subset of MHC-I ligands, although exceptions do exist . Distinct KIR allotypes can have differing binding affinities for particular MHC-I allotypes. These differences in KIR/MHC-I binding affinity can alter KIR signaling and NK cell activity . In addition to KIR genotype, MHC-I genotype must be considered since it determines the set of available KIR ligands and since it is possible to express a KIR with or without its cognate MHC-I molecule [10, 17].
Specific KIR/MHC-I genotypes have been implicated as a factor contributing to the immune control of multiple human diseases including hepatitis C virus, human papilloma virus, malaria, and human immunodeficiency virus (HIV) [6–9, 18]. One of the best-studied examples of KIR/MHC-I genetics and disease is that of KIR3DL1/KIR3DS1 and HLA-Bw4 in HIV infection. Individuals who express specific KIR3DL1/KIR3DS1 alleles in combination with certain HLA-B alleles containing the Bw4 motif show slower progression to AIDS [8, 9]. This genetic association has more recently been supported by functional data demonstrating that NK cells expressing KIR3DS1 have increased anti-HIV activity against target cells expressing HLA-Bw4, although the underlying mechanism remains to be elucidated .
Despite advances in our understanding of KIR biology, the mechanisms through which specific KIR/MHC-I combinations influence disease progression are not fully understood. This is at least partially due to the complexity of KIR/MHC-I genotypes and difficulty in identifying KIR/MHC-I matched cohorts. Rhesus macaques (Macaca mulatta) are an established and widely used experimental model system for many human diseases, including immunodeficiency virus . The advantages of studying infectious disease in rhesus macaques include the ability to manipulate the dose, route, and strain of the infectious agent, as well as the ability to analyze specimens from defined time points. For the study of KIR activity, perhaps the most important advantage is the ability to select subjects based on genetics. This benefit is evidenced by the work in macaques to elucidate the role of the cytotoxic T-lymphocyte (CTL) response in immunodeficiency viral infection, which is also heavily dependent on host genetics [21, 22].
Macaque KIRs have received less study than human KIRs. While previous work shows that macaque KIRs have structure and genomic organization similar to human KIRs, and suggests that they play a similar functional role, these studies also demonstrate that there has been considerable evolution within macaque KIRs since the species diverged . While 15 genes have been described in humans, the number and identity of the KIR genes present in macaques is distinct. Developing an understanding of the KIR genes present in this species and an overall assessment of KIR genetic diversity is a matter of practical importance for the use of macaques as a model for KIR function. Using cDNA sequences, an initial model for macaque KIR genetic organization was formed containing 18 putative KIR groups [23, 24]. In addition to the sequence of KIR transcripts, the genomic sequence of one rhesus macaque KIR haplotype has been described . More recent studies have added to the total number of described macaque KIR sequences [23, 24, 26–28]. With more sequence data available, phylogenetic relationships became clearer, and the model of macaque KIR genetics has been refined. This body of work has been used to create a model for macaque KIR genetic organization and to develop a formal system of nomenclature (Guethlein et al, in preparation).
Here we present the results of a survey of rhesus macaque KIR genetics. Using full-length cloning, we identified 47 novel full-length rhesus macaque KIRs, substantially increasing the library of known sequences. Using this expanded library, we performed phylogenetic analysis supporting the existence of 22 rhesus macaque KIR genes. Together with previously published KIR sequences, this provides a framework with which to describe KIR genetics in this species. In addition to improving our understanding of macaque KIRs at the population level, we developed a novel pyrosequencing-based approach for KIR genotyping. This technique provides both comprehensive KIR genotyping and frequency estimates for expression of each KIR transcript. The findings presented here, along with the novel techniques set forth, should serve as a foundation for further research on rhesus KIR genetics and for defining KIR function in this important animal model.
Animal Care and Specimen Processing
Animals used in this study were housed and cared for by the trained veterinary staff at the Wisconsin National Primate Research Center (WNPRC) or the New England Primate Research Center (NEPRC). All procedures were approved by the host institution's Animal Care and Use Committee. Nucleic acid was obtained from peripheral blood mononuclear cells (PBMC) or purified natural killer (NK) cells, as indicated. RNA purification was accomplished using either the MagnaPure LC Total Nucleic Acid Purification kit (Roche, Branford, CT) or the DNA/RNA Allprep Kit (QIAGEN, Valencia, CA) according to the manufacturer's instructions.
NK cells were isolated from whole PBMC by negative magnetic bead fractionation. First, PBMC were incubated for 20 minutes at room temperature in 0.1% BSA/PBS with a cocktail of cross-reactive human monoclonal IgG antibodies composed of the following: anti-CD3 (clone SP34-2, BD Biosciences, La Jolla, CA), anti-CD14 (clone M5E2, BD Biosciences), anti-CD40 (clone 5C3, BD Biosciences), and anti-CD66/CEACAM (clone TET2, AbCam, Cambridge, MA or Santa Cruz Biotechnology, Santa Cruz, CA). Next, antibody-coated PBMC were washed and resuspended in 0.1% BSA/PBS then incubated for 35 minutes at room temperature with Pan-IgG Dynabeads (Dynal Biotech, Norway) at a 4:1 bead-to-cell ratio. The suspension was then placed on a Dynal magnet and the unbound cells were collected. Purity was assessed by flow cytometry with >90% of collected cells routinely bearing an NK cell phenotype of NKG2A+CD8+CD3-. All acquisitions were made on a FACSCalibur (BD Biosciences) and analyzed using FlowJo software (Tree Star Inc., Ashland, OR).
Full-Length cDNA Cloning and Sequencing
First-strand cDNA was synthesized using the Superscript III First-Strand One-Step RT-PCR kit (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. PCR amplification was performed using Phusion high-fidelity polymerase (New England Biolabs, Ipswich, MA) and the following external primers: 5'-CAGCACCATGTCGCTCAT-3' and 5'-GGGGTCAAGTGAAGTGGAGA-3'. PCR conditions were: 98°C for 30 s, 28 cycles of 98°C for 5 s, 63°C for 1 s, 72°C for 20 s, and a final extension at 72°C for 5 min. PCR products were cloned into pCR-Blunt TOPO (Invitrogen, Carlsbad, CA) and bidirectionally sequenced using DYEnamic ET Terminator cycle sequencing kit (GE Healthcare, Piscataway, NJ). Internal primers used in sequencing were 5'-AACCTTCCCTCCTGGCC-3 and 5'-TTGGTTCAGTGGGTGAAGGCCAA-3.' CodonCode Aligner (CodonCode Corporation, Dedham, MA) was used for sequence analysis, and in order to minimize error introduced by PCR artifacts, novel alleles were only included when three or more identical full-length cDNA clones were observed. Novel sequences have been deposited in Genbank (Additional file 1, Table S1). Novel full-length sequences were assigned formal names through the Immuno Polymorphism Database .
The cDNA sequences obtained in this analysis and from previous studies [23, 25, 27, 28, 30] were aligned using Clustal X  and manually corrected in BioEdit (Ibis Therapeutics, Carlsbad, CA). Phylogenetic trees for the complete dataset were made using both neighbor-joining (1000 replicates, pairwise deletion, Tamura-Nei, in MEGA4) and parsimony (1000 replicates in Paup). These trees were used to divide the sequences into Mamu-KIR3DL20, -KIR2DL04, -KIR1D, and -KIR3D (lineage II) groups. Subsequent analysis was restricted to the lineage II dataset using the same methods. Alleles of Mamu-KIR3DL11, -KIR3DS01, -KIR3DS03, -KIR3DSW07, and -KIR3DSW08 were not obtained in this study and sequences for these genes were taken from GenBank [23, 27, 30, 32].
A dataset containing consensus sequences for each of the lineage II KIR genes was constructed using all known sequences to compute the consensus sequence. For groups containing only two allotypes, one of the allotypes was chosen to represent the consensus. The sequences used are indicated in Additional file 1, Figure S1. The individual extracellular Ig domains (D0, D1, and D2) were analyzed separately using the methods described above. The stem, transmembrane and cytoplasmic tails were not included in this analysis as previous reports have shown that the stem, transmembrane, and tail of macaque activating KIRs share similarity to KIR2DL4 and are distinct .
PCR Amplification and Pyrosequencing
As with our full-length products, cDNA was synthesized using the Superscript III First-Strand One-Step RT-PCR kit (Invitrogen, Carlsbad, CA). cDNA-PCR amplicons spanning 623 base pairs of the D1 and D2 domains were synthesized using Phusion high-fidelity polymerase (New England Biolabs, Ipswich, MA). Each PCR primer contained a target-specific sequence, an MID tag, and an adapter sequence (Additional file 1, Table S2). PCR conditions were: 98°C for 30 s, 28-33 cycles of 98°C for 5 s, 61°C for 1 s, 72°C for 20 s, and a final extension at 72°C for 5 min. cDNA-PCR product purification was accomplished using Ampure XP beads (Agencourt, Beverly, MA) according to the manufacturer's instructions. Amplicons were then normalized to equimolar concentrations and grouped into pools of twelve samples for Titanium amplicon pyrosequencing. Emulsion PCR, Roche/454 Titanium amplicon pyrosequencing, image processing, and base calling were performed according to the manufacturer's instructions (Roche/454 Life Sciences, Branford, CT) at the University of Illinois at Urbana-Champaign High-Throughput Sequencing Center. Each pool of twelve samples was sequenced in one-sixteenth of a 70 × 75 PicoTiterPlate.
Pyrosequencing flowgram data was processed using a custom analysis pipeline. Briefly, data were trimmed by sequence quality and aligned against a reference database of all known macaque KIR sequences using the Mosaik aligner (http://code.google.com/p/mosaik-aligner/). The reference library of KIR sequences was obtained from the Immuno Polymorphism Database . Polymorphisms between reads and the reference sequences were scored with custom scripts that utilized Samtools and BioPerl [33, 34]. The source code for this pipeline can be obtained from a subversion repository (https://hedgehog.fhcrc.org/tor/stedi/trunk/server/customModules/SequenceAnalysis). The pipeline itself has been integrated into the LabKey Software platform as the SequenceAnalysis module, which provides a graphical, web-based platform to initiate analysis pipelines and view results. LabKey is a free, open source software package available at http://www.labkey.org. Sanger sequence data was analyzed using CodonCode Aligner (CodonCode Corporation, Dedham, MA).
In order to reduce errors introduced by PCR artifacts, KIR sequences were only considered to be present in an animal if they represented one percent or more of total KIR sequence reads from that animal. In order to identify novel alleles not present in the reference library, unaligned sequences were then assembled in CodonCode Aligner at 100% identity. BLAST analysis was performed for the resulting contigs against a database of published Mamu-KIR sequences. Unaligned sequences were deemed novel when they represented at least one percent of total sequence reads from at least one animal and did not represent a potential insertion/deletion error in the pyrosequencing base-calling.
Rhesus macaque KIR diversity
KIR genotype has a significant influence on NK cell activity. Studying the role of macaque KIR genetics in disease pathogenesis first requires an understanding of total diversity within the population and a framework within which to describe it. To date, 149 distinct full-length Mamu-KIR sequences have been deposited in Genbank. By comparison, there are more than 615 distinct KIR alleles identified in humans--more than four times as many alleles as have been identified to date in rhesus macaques . Thus, the previously catalogued alleles likely represent only a fraction of total Mamu-KIR diversity. In order to expand the repertoire of known Mamu-KIR alleles, we performed full-length cloning and sequencing of KIR alleles from 17 Indian rhesus macaques. These animals yielded 47 novel KIR alleles, a substantial expansion of documented rhesus macaque KIR diversity (Additional file 1, Table S1). The novel sequences have been assigned names following the KIR genes and nomenclature conventions established in the Non-human Primate KIR Nomenclature Report (Guethlein et al, in preparation)1.
Comprehensive KIR genotyping by pyrosequencing
The expanded library of macaque KIR sequences described in this publication and others has enabled the creation of a framework to describe macaque KIRs, and its phylogenetic analysis suggests that the most common KIR genes have been identified [24–28, 30, 32]. For the study of KIRs in disease pathogenesis, one of the most basic requirements is the ability to identify the KIRs expressed by individual subjects. KIRs pose many challenges for genotyping: each subject expresses a distinct number of KIRs, there is extensive sequence homology between KIR transcripts, splice variants may be functionally significant, and pseudogenes are common. The cloning-based strategy we employed for allele discovery can be used to provide genotypes of individual subjects; however, this method is labor intensive and will frequently miss low-abundance transcripts due to the limited number of clones examined. Techniques such as sequence-specific PCR (SSP) can be used to identify the presence or absence of a particular gene or allele; however, sequence homology between KIRs complicates primer design, and a large number of primer pairs would be required for comprehensive genotyping.
A key advantage of pyrosequencing is that it provides estimates of the relative transcript frequency for each KIR. This is a dimension not usually captured by genotyping techniques. The three animals in Figure 5 share a KIR haplotype containing Mamu-KIR1D, Mamu-KIR3DL1*001, Mamu-KIR3DL10*004 and Mamu-KIR3DS04*002 (Figure 5, striped bars). KIR expression is influenced by the complete KIR and MHC genotype of the subject [10, 17, 39]. Work in humans has shown that KIR genotype is only loosely predictive of KIR RNA expression . While the animals in Figure 5 share one KIR haplotype, their second KIR haplotypes are distinct, and none are MHC identical (data not shown). We observe considerable differences in the expression level of the KIRs on the shared haplotype, which is likely attributable to differences in KIR/MHC genotype. While these findings are not unexpected given the complex regulation of KIR expression, they do underscore the need to examine factors beyond the simple presence or absence of a given KIR.
Population survey of KIR gene frequency
Using the pyrosequencing data generated from our cohort of 61 animals, we compared the relative contribution of each KIR gene to the total KIR transcripts identified in each animal (Figure 8B). Although pyrosequencing provides information about the KIR allele, genotyping results were condensed to the gene level for this comparison. The error bars representing the mean and SEM for each gene demonstrate highly variable expression levels for most genes between subjects, with a few KIRs consistently expressed at either high (i.e. Mamu-KIR3DL08) or low (i.e. Mamu-KIR3DSw09) levels. As observed in Figure 5, the expression level of a given KIR gene can differ even between genetically similar subjects and is likely influenced by the complete KIR/MHC genotype of that subject. While it would be interesting to examine the relative expression of each KIR in the context of MHC genotype, macaques can express up to 20 distinct MHC class I transcripts and only a handful of macaque KIR/MHC binding partners have been identified [42, 43]. Therefore this analysis is not practical until physiological macaque KIR/MHC interactions are better understood.
Rhesus macaque KIR haplotypes
Killer immunoglobulin-like receptor signaling is implicated in the immune response to numerous human pathogens, yet elucidating the role of KIR mediated signaling in disease pathogenesis is difficult in human subjects. The results of this study advance our understanding of macaque KIRs, enabling the study of KIR activity in this important non-human primate model for many human diseases. This study identified 47 novel full-length rhesus macaque KIRs, a substantial increase in the number of published sequences. Combined with previously published data, our results confirm the existence of 22 common macaque KIR genes, with extensive allelic variation within each gene (Guethlein et al, in preparation). This model of macaque KIR genetics provides an essential framework within which to describe and characterize macaque KIRs. In addition, among the novel sequences found using pyrosequencing, two sequences provide evidence for the existence of either a divergent lineage of Mamu-KIR3DS03 or an additional gene. While no KIR gene was present in all subjects, Mamu-KIR3DL01 was expressed in 84% of subjects and 8 genes were present in >50% of the cohort. This frequency information may be useful to prioritize KIRs for further functional characterization or the design of cohorts. The comparative lack of expressed framework genes is a distinction from human KIR haplotypes, which may be related to differences in MHC-I genetics. Humans express a maximum of six distinct HLA molecules, from 3 genomic loci. Macaques lack MHC-I C, but can express as many as 20 distinct MHC-I A/B alleles . The expansion of macaque lineage II KIR3D loci, with a larger number of loci and few dominant genes, likely mirrors the expansion of macaque MHC-I A/B.
We also present a novel pyrosequencing-based approach for KIR genotyping. While this technique was developed in macaques, it could easily be applied to other species, including humans. The ability to characterize the KIR genotype of individual subjects is a basic requirement for the study of KIR function; however, the KIR region presents many challenges for genotyping. The approach we present comprehensively identifies the expressed KIR transcripts and provides a semi-quantitative measure of the relative expression level for each KIR. Our data demonstrate that even subjects sharing a KIR haplotype can have widely different expression levels of these shared KIRs. NK cells undergo complex regulation of KIR expression [10, 17]. NK clones expressing fewer distinct KIRs can have a reduced activation threshold under certain conditions, resulting in enhanced NK cell activity . The relative expression of each KIR therefore provides potentially important functional information.
While this and other recent studies have advanced our understanding of the genetic organization and diversity of macaque KIRs, KIR activity must be understood in the context of MHC genotype. The limited knowledge of functional KIR/MHC binding partners remains a key obstacle. Recent work has identified multiple macaque KIR/MHC-I interactions, including allotypes of Mamu-KIR3DL05, -KIR3DLW03, -KIR3DL11 and -KIR3DS05 [43, 46]. Preliminary evidence suggests the residues of the Bw4/Bw6 motifs influence KIR/MHC binding in macaques, although the important residues differ from those in humans. Expanding the number of identified KIR/MHC partners and further defining the motifs necessary for macaque KIR/MHC interaction remains essential for the advancement of the field.
The data and techniques presented here have implications for the study of many diseases using rhesus macaques as a model system and for the KIR field as a whole. The ability to study KIRs in a nonhuman primate model creates an opportunity for significant advancement in our understanding of KIRs in human disease. The novel high-throughput KIR genotyping method we developed has implications for many species, including potential application in humans, and the approach could be adapted for other polymorphic immune loci.
1 A note on nomenclature: KIR nomenclature reflects both the domain structure and gene designation of the sequence. For example, an allele named "KIR3DL01*001" denotes a KIR with 3 extracellular immunoglobulin-like domains (3D). The "L" indicates that this allele's protein product has a long, inhibitory cytoplasmic tail, while an "S" would instead indicate that the protein product had a short, activating cytoplasmic tail. The next two digits refer to the gene, in this case KIR3DL01. Finally, the digits after the asterisk, "001" in this example, refer to the specific allele.
2 Human KIRs are divided into four lineages. Lineage I includes KIR2D genes having a D0 (immunoglobulin-like domain 0) plus D2 configuration such as KIR2DL4 and KIR2DL5; lineage II includes the KIR3DL genes that bind MHC-A and -B epitopes; lineage III includes KIR3D or KIR2D genes with a D1 plus D2 domain configuration that bind MHC-C epitopes, and lineage V is represented by KIR3DL3. Lineage IV, which included Mamu-KIR3DL01 and Mamu-KIR3DL10, was originally described in Rajalingam, et al. . Further work has instead grouped these KIRs into lineage II and removed lineage IV .
We thank Roger Wiseman and Simon Lank for advising on technical aspects of this study and for thoughtful comments on this manuscript. We also thank Chris Wright and the staff of the University of Illinois High Throughput Sequencing Center. Finally, we thank Jon Warren and the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), for support. The contents of this manuscript are solely attributed to the authors and do not necessarily represent the official views of the research sponsors. This publication was made possible in part by grants P51 RR000167 and P51 RR000168 from the National Center for Research Resources (NCRR), a component of the NIH, to the Wisconsin National Primate Research Center and the New England Primate Research Center, respectively along with R24 RR021745 to D.H.O., AI071306 to R.P.J. and AI24258 to PP. Development of KIR pyrosequencing was also supported by the NIH/NIAID Reagent Resource Support Program for AIDS Vaccine Development, Quality Biological, Inc., Gaithersburg, MD. The project was also supported by CHAVI/HVTN Early Career Investigator award, grant number U19 AI 067854-04, to R.K.R.
- Lanier LL: Evolutionary struggles between NK cells and viruses. Nat Rev Immunol. 2008, 8 (4): 259-268. 10.1038/nri2276.PubMedPubMed CentralView ArticleGoogle Scholar
- Gardiner CM: Killer cell immunoglobulin-like receptors on NK cells: the how, where and why. Int J Immunogenet. 2008, 35 (1): 1-8.PubMedView ArticleGoogle Scholar
- Parham P: MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol. 2005, 5 (3): 201-214. 10.1038/nri1570.PubMedView ArticleGoogle Scholar
- Beck JC, Wagner JE, DeFor TE, Brunstein CG, Schleiss MR, Young JA, Weisdorf DH, Cooley S, Miller JS, Verneris MR: Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation. Biol Blood Marrow Transplant. 2010, 16 (2): 215-222. 10.1016/j.bbmt.2009.09.019.PubMedView ArticleGoogle Scholar
- Miller JS, Cooley S, Parham P, Farag SS, Verneris MR, McQueen KL, Guethlein LA, Trachtenberg EA, Haagenson M, Horowitz MM, et al: Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT. Blood. 2007, 109 (11): 5058-5061. 10.1182/blood-2007-01-065383.PubMedPubMed CentralView ArticleGoogle Scholar
- Khakoo S, Thio C, Martin M, Brooks C, Gao X, Astemborski J, Cheng J, Goedert J, Vlahov D, Hilgartner M, et al: HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science. 2004, 305 (5685): 872-874. 10.1126/science.1097670.PubMedView ArticleGoogle Scholar
- Bonagura VR, Du Z, Ashouri E, Luo L, Hatam LJ, DeVoti JA, Rosenthal DW, Steinberg BM, Abramson AL, Gjertson DW, et al: Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis. Hum Immunol. 2010, 71 (2): 212-219. 10.1016/j.humimm.2009.10.009.PubMedView ArticleGoogle Scholar
- Martin M, Qi Y, Gao X, Yamada E, Martin J, Pereyra F, Colombo S, Brown E, Shupert W, Phair J, et al: Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet. 2007, 39 (6): 733-740. 10.1038/ng2035.PubMedPubMed CentralView ArticleGoogle Scholar
- Martin M, Gao X, Lee J, Nelson G, Detels R, Goedert J, Buchbinder S, Hoots K, Vlahov D, Trowsdale J, et al: Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet. 2002, 31 (4): 429-434.PubMedGoogle Scholar
- Kim S, Poursine-Laurent J, Truscott S, Lybarger L, Song Y, Yang L, French A, Sunwoo J, Lemieux S, Hansen T, et al: Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature. 2005, 436 (7051): 709-713. 10.1038/nature03847.PubMedView ArticleGoogle Scholar
- Moretta L, Moretta A: Killer immunoglobulin-like receptors. Curr Opin Immunol. 2004, 16 (5): 626-633. 10.1016/j.coi.2004.07.010.PubMedView ArticleGoogle Scholar
- Wilson M, Torkar M, Haude A, Milne S, Jones T, Sheer D, Beck S, Trowsdale J: Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci USA. 2000, 97 (9): 4778-4783. 10.1073/pnas.080588597.PubMedPubMed CentralView ArticleGoogle Scholar
- Hsu K, Chida S, Geraghty D, Dupont B: The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev. 2002, 190: 40-52. 10.1034/j.1600-065X.2002.19004.x.PubMedView ArticleGoogle Scholar
- Witt C, Dewing C, Sayer D, Uhrberg M, Parham P, Christiansen F: Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination. Transplantation. 1999, 68 (11): 1784-1789. 10.1097/00007890-199912150-00024.PubMedView ArticleGoogle Scholar
- Vilches C, Parham P: KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol. 2002, 20: 217-251. 10.1146/annurev.immunol.20.092501.134942.PubMedView ArticleGoogle Scholar
- Yamada S, Hatta M, Staker BL, Watanabe S, Imai M, Shinya K, Sakai-Tagawa Y, Ito M, Ozawa M, Watanabe T: Biological and structural characterization of a host-adapting amino acid in influenza virus. PLoS Pathog. 2010, 6 (8):
- Shilling HG, Young N, Guethlein LA, Cheng NW, Gardiner CM, Tyan D, Parham P: Genetic control of human NK cell repertoire. J Immunol. 2002, 169 (1): 239-247.PubMedView ArticleGoogle Scholar
- Hansen D, D'Ombrain M, Schofield L: The role of leukocytes bearing Natural Killer Complex receptors and Killer Immunoglobulin-like Receptors in the immunology of malaria. Curr Opin Immunol. 2007, 19 (4): 416-423. 10.1016/j.coi.2007.07.011.PubMedView ArticleGoogle Scholar
- Alter G, Martin MP, Teigen N, Carr WH, Suscovich TJ, Schneidewind A, Streeck H, Waring M, Meier A, Brander C, et al: Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med. 2007, 204 (12): 3027-3036. 10.1084/jem.20070695.PubMedPubMed CentralView ArticleGoogle Scholar
- Bontrop RE, Watkins DI: MHC polymorphism: AIDS susceptibility in non-human primates. Trends Immunol. 2005, 26 (4): 227-233. 10.1016/j.it.2005.02.003.PubMedView ArticleGoogle Scholar
- O'Connor D, Allen T, Watkins D: Cytotoxic T-lymphocyte escape monitoring in simian immunodeficiency virus vaccine challenge studies. DNA Cell Biol. 2002, 21 (9): 659-664. 10.1089/104454902760330192.PubMedView ArticleGoogle Scholar
- Loffredo J, Burwitz B, Rakasz E, Spencer S, Stephany J, Vela J, Martin S, Reed J, Piaskowski S, Furlott J, et al: The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape. J Virol. 2007, 81 (6): 2624-2634. 10.1128/JVI.01912-06.PubMedView ArticleGoogle Scholar
- Hershberger K, Shyam R, Miura A, Letvin N: Diversity of the killer cell Ig-like receptors of rhesus monkeys. J Immunol. 2001, 166 (7): 4380-4390.PubMedView ArticleGoogle Scholar
- Grendell RL, Hughes AL, Golos TG: Cloning of rhesus monkey killer-cell Ig-like receptors (KIRs) from early pregnancy decidua. Tissue Antigens. 2001, 58 (5): 329-334. 10.1034/j.1399-0039.2001.580507.x.PubMedView ArticleGoogle Scholar
- Sambrook J, Bashirova A, Palmer S, Sims S, Trowsdale J, Abi-Rached L, Parham P, Carrington M, Beck S: Single haplotype analysis demonstrates rapid evolution of the killer immunoglobulin-like receptor (KIR) loci in primates. Genome Res. 2005, 15 (1): 25-35. 10.1101/gr.2381205.PubMedPubMed CentralView ArticleGoogle Scholar
- Blokhuis JH, van der Wiel MK, Doxiadis GG, Bontrop RE: Evidence for balancing selection acting on KIR2DL4 genotypes in rhesus macaques of Indian origin. Immunogenetics. 2009, 61 (7): 503-512. 10.1007/s00251-009-0379-6.PubMedView ArticleGoogle Scholar
- Kruse PH, Rosner C, Walter L: Characterization of rhesus macaque KIR genotypes and haplotypes. Immunogenetics. 2010, 62 (5): 281-293. 10.1007/s00251-010-0433-4.PubMedView ArticleGoogle Scholar
- Bimber BN, Moreland AJ, Wiseman RW, Hughes AL, O'Connor DH: Complete characterization of killer Ig-like receptor (KIR) haplotypes in Mauritian cynomolgus macaques: novel insights into nonhuman primate KIR gene content and organization. J Immunol. 2008, 181 (9): 6301-6308.PubMedPubMed CentralView ArticleGoogle Scholar
- Robinson J, Marsh SG: IPD: the Immuno Polymorphism Database. Methods Mol Biol. 2007, 409: 61-74. 10.1007/978-1-60327-118-9_4.PubMedView ArticleGoogle Scholar
- Blokhuis JH, van der Wiel MK, Doxiadis GG, Bontrop RE: The mosaic of KIR haplotypes in rhesus macaques. Immunogenetics. 2010, 62 (5): 295-306. 10.1007/s00251-010-0434-3.PubMedPubMed CentralView ArticleGoogle Scholar
- Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22 (22): 4673-4680. 10.1093/nar/22.22.4673.PubMedPubMed CentralView ArticleGoogle Scholar
- Blokhuis JH, Doxiadis GG, Bontrop RE: A splice site mutation converts an inhibitory killer cell Ig-like receptor into an activating one. Mol Immunol. 2009, 46 (4): 640-648. 10.1016/j.molimm.2008.08.270.PubMedView ArticleGoogle Scholar
- Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R: The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009, 25 (16): 2078-2079. 10.1093/bioinformatics/btp352.PubMedPubMed CentralView ArticleGoogle Scholar
- Stajich JE, Block D, Boulez K, Brenner SE, Chervitz SA, Dagdigian C, Fuellen G, Gilbert JG, Korf I, Lapp H, et al: The Bioperl toolkit: Perl modules for the life sciences. Genome Res. 2002, 12 (10): 1611-1618. 10.1101/gr.361602.PubMedPubMed CentralView ArticleGoogle Scholar
- Robinson J, Mistry K, McWilliam H, Lopez R, Marsh SG: IPD--the Immuno Polymorphism Database. Nucleic Acids Res. 2010, D863-869. 38 Database
- Hershberger KL, Kurian J, Korber BT, Letvin NL: Killer cell immunoglobulin-like receptors (KIR) of the African-origin sabaeus monkey: evidence for recombination events in the evolution of KIR. Eur J Immunol. 2005, 35 (3): 922-935. 10.1002/eji.200425408.PubMedView ArticleGoogle Scholar
- Rajalingam R, Parham P, Abi-Rached L: Domain shuffling has been the main mechanism forming new hominoid killer cell Ig-like receptors. J Immunol. 2004, 172 (1): 356-369.PubMedView ArticleGoogle Scholar
- Bashirova AA, Martin MP, McVicar DW, Carrington M: The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet. 2006, 7: 277-300. 10.1146/annurev.genom.7.080505.115726.PubMedView ArticleGoogle Scholar
- Kim S, Sunwoo JB, Yang L, Choi T, Song YJ, French AR, Vlahiotis A, Piccirillo JF, Cella M, Colonna M, et al: HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc Natl Acad Sci USA. 2008, 105 (8): 3053-3058. 10.1073/pnas.0712229105.PubMedPubMed CentralView ArticleGoogle Scholar
- McErlean C, Gonzalez AA, Cunningham R, Meenagh A, Shovlin T, Middleton D: Differential RNA expression of KIR alleles. Immunogenetics. 2010, 62 (7): 431-440. 10.1007/s00251-010-0449-9.PubMedView ArticleGoogle Scholar
- Sharma D, Bastard K, Guethlein LA, Norman PJ, Yawata N, Yawata M, Pando M, Thananchai H, Dong T, Rowland-Jones S, et al: Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402. J Immunol. 2009, 183 (7): 4569-4582. 10.4049/jimmunol.0901734.PubMedPubMed CentralView ArticleGoogle Scholar
- Wiseman RW, Karl JA, Bimber BN, O'Leary CE, Lank SM, Tuscher JJ, Detmer AM, Bouffard P, Levenkova N, Turcotte CL, et al: Major histocompatibility complex genotyping with massively parallel pyrosequencing. Nat Med. 2009, 15 (11): 1322-1326. 10.1038/nm.2038.PubMedPubMed CentralView ArticleGoogle Scholar
- Rosner C, Kruse PH, Hermes M, Otto N, Walter L: Rhesus Macaque Inhibitory and Activating KIR3D Interact with Mamu-A-Encoded Ligands. J Immunol. 2011, 186 (4): 2156-2163. 10.4049/jimmunol.1002634.PubMedView ArticleGoogle Scholar
- Budde ML, Lhost JJ, Burwitz BJ, Becker EA, Burns CM, O'Connor SL, Karl JA, Wiseman RW, Bimber BN, Zhang GL, et al: Transcriptionally Abundant Major Histocompatibility Complex Class I Alleles are Fundamental to Non-Human Primate SIV-specific CD8+ T Cell Responses. J Virol. 2011Google Scholar
- Carrington M, Martin MP, van Bergen J: KIR-HLA intercourse in HIV disease. Trends Microbiol. 2008, 16 (12): 620-627. 10.1016/j.tim.2008.09.002.PubMedPubMed CentralView ArticleGoogle Scholar
- Colantonio AD, Bimber BN, Neidermyer WJ, Reeves RK, Alter G, Altfeld M, Johnson RP, Carrington M, O'Connor DH, Evans DT: KIR Polymorphisms Modulate Peptide-Dependent Binding to an MHC Class I Ligand with a Bw6 Motif. PLoS Pathog. 2011, 7 (3): e1001316-10.1371/journal.ppat.1001316.PubMedPubMed CentralView ArticleGoogle Scholar
- Guethlein LA, Older Aguilar AM, Abi-Rached L, Parham P: Evolution of killer cell Ig-like receptor (KIR) genes: definition of an orangutan KIR haplotype reveals expansion of lineage III KIR associated with the emergence of MHC-C. J Immunol. 2007, 179 (1): 491-504.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.